查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
神經復健市場：2023年至2028年預測
市場調查報告書
商品編碼
1410026

神經復健市場：2023年至2028年預測

Neurorehabilitation Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計神經復健市場在預測期內將以 5.79% 的複合年成長率成長。

神經復健是指旨在促進受神經系統疾病或災難影響的患者的實際康復、重建多功能性和解決個人滿意度的各種治療、調解和硬體。Masu。中風、脊髓損傷、帕金森氏症感染疾病、不同的硬化症和不同的問題都可能在其中。

由於神經系統疾病復發率的增加、機器的加強以及政府的持續努力，神經復健的市場規模正在快速成長。隨著該領域的建立，調查方法和硬體有進一步進步的巨大潛力，最終為神經病變患者帶來改善的結果和更好的生活。

市場促進因素

神經系統疾病盛行率增加：

隨著中風、心肌梗塞和硬化症等神經系統疾病發生率的增加，人們對神經復健藥物的興趣也隨之增加。市場擴張背後的驅動力是不斷擴大的患者群體對有效康復解決方案的需求不斷成長。

復健設備的技術進步：

機器人外骨骼、腦機介面和虛擬實境系統等先進復健技術已經徹底改變了神經復健。這些最先進的儀器提供精準和客製化的治療活動，吸引了醫療服務專業人員並鼓勵了商業領域的發展。

越來越關注功能恢復和生活品質：

人們越來越關注改善神經系統感染疾病患者的實際康復和提高個人滿意度。神經復健透過提供全面的復健計劃，導致需求增加和市場擴張，在實現這些目標方面發揮關鍵作用。

神經復健市場的主要企業

  • 美敦力公司（Medtronic PLC）：美敦力公司是一家全球臨床創新供應商，提供全面的神經復健設備和治療方法。神經刺激框架、植入式設備和其他治療神經系統疾病的新答案對該公司的產品組合非常重要。
  • DIH 醫療集團： DIH 的子公司 Hocoma AG 生產基於感測器的神經復健系統。該公司的貢獻包括自動化治療框架、擴增實境階段以及用於上肢和下肢復健的感測器輔助復健設備。
  • Saebo賽博有限公司是一家專門從事上肢復健設備及解決方案的公司。我們提供有助於改善手部和手臂功能的產品，例如功能性矯正器具和機器人治療系統。

預計北美將佔據神經復健市場的重要佔有率。

由於多種因素，預計北美將佔據很大的市場佔有率。首先，該地區擁有先進的醫療基礎設施，包括專門的復健中心和研究機構，鼓勵使用神經復健技術。此外，神經系統疾病在北美很常見，這增加了對適當復健方法的需求。此外，有利的報銷法規和促進神經復健的政府活動也有助於提高該地區的神經復健市場佔有率。此外，北美是一些重要公司的所在地，這些公司在研發業務上的持續支出正在加強他們在神經復健市場的地位。

主要進展：

  • 2023 年 2 月，Lupin Limited 在孟買開設了世界上第一個電腦和機器人神經復健中心 Atharv Benefit。該中心為脊髓和腦損傷以及帕金森氏症、多發性腦性麻痹系統疾病患者提供復健計畫。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表

第2章調查方法

  • 調查資料
  • 調查過程

第3章執行摘要

  • 研究亮點

第4章市場動態

  • 市場促進因素
  • 市場抑制因素
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析

第5章神經復健市場：依產品

  • 介紹
  • 神經機器人系統
  • 穿戴式裝置
  • 腦機介面
  • 非侵入式模擬器
  • 神經假體
  • 其他

第6章神經復健市場：依應用分類

  • 介紹
  • 中風
  • 創傷性腦損傷 (TBI)
  • 脊髓損傷（SCI）
  • 帕金森氏症
  • 腦性麻痹
  • 其他

第7章神經復健市場：依最終用戶分類

  • 介紹
  • 醫院
  • 診所
  • 復健中心
  • 居家照護環境

第8章神經復健市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 印尼
    • 台灣
    • 其他

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作

第10章 公司簡介

  • Medtronic PLC
  • Abbott Laboratories
  • BIONIK
  • Ekso Bionics Holdings Inc.
  • DIH Medical Group
  • ReWalk Robotics
  • BioXtreme Ltd.
  • Kinova
  • Saebo Inc.
簡介目錄
Product Code: KSI061615682

The neurorehabilitation market is estimated to grow at a CAGR of 5.79% during the forecast period.

Neurorehabilitation alludes to different treatments, mediations, and hardware that are planned to advance utilitarian recuperation, reestablish versatility, and work on personal satisfaction in patients experiencing neurological illnesses or mishaps. Stroke, spinal rope injury, Parkinson's infection, different sclerosis, and different issues might be among them.

The Neurorehabilitation market size is growing quickly, attributable to an expansion in the recurrence of neurological illnesses, mechanical enhancements, and steady government endeavors. As the discipline is created, there is huge potential for extra advances in neurorehabilitation methodology and hardware, eventually prompting improved results and a better life for those with neurological impedances.

Market Drives:

Increasing Prevalence of Neurological Disorders:

As the rate of neurological ailments like stroke, horrendous mind injury, and numerous cases of sclerosis rises, so does the interest in neurorehabilitation medicines. Market expansion is driven by the growing demand for effective rehabilitation solutions from this expanding patient population.

Technological Advancements in Rehabilitation Devices:

Advanced rehabilitation technologies like robotic exoskeletons, brain-computer interfaces, and virtual reality systems have revolutionized neurorehabilitation. These state-of-the-art contraptions convey precise and customized treatment activities, tempting medical services experts and impelling business sector development.

Growing Focus on Functional Recovery and Quality of Life:

There is a developing accentuation on upgrading practical recuperation and working on personal satisfaction for those with neurological infections. By providing comprehensive rehabilitation programs, neurorehabilitation plays a crucial role in achieving these goals, leading to increased demand and market expansion.

Key Players in the Neurorehabilitation Market:

  • Medtronic PLC: Medtronic is a worldwide clinical innovation supplier that gives an exhaustive scope of neurorehabilitation gear and treatments. Neurostimulation frameworks, implantable gadgets, and other new answers for the treatment of neurological ailments are important for their portfolio.
  • DIH Medical Group: DIH's subsidiary Hocoma AG manufactures sensor-based neurorehabilitation systems. Automated treatment frameworks, augmented reality stages, and sensor-helped restoration gear for upper and lower appendage recovery are among their contributions.
  • Saebo Inc.: Saebo is a company that specializes in upper limb rehabilitation equipment and solutions. They provide several goods, including functional orthoses and robotic treatment systems, to help people with neurological problems improve their hand and arm function.

North America is anticipated to hold a considerable neurorehabilitation market share.

North America is projected to account for a significant market share which is attributable to various factors. Firstly, the region contains sophisticated healthcare infrastructure, such as specialized rehabilitation centers and research organizations, which encourage the use of neurorehabilitation technology. Also, neurological illnesses are common in North America, increasing the requirement for appropriate rehabilitation methods. Furthermore, favorable reimbursement regulations and government activities promoting neurorehabilitation contribute to the region's neurorehabilitation market share. Furthermore, the presence of significant companies in North America, as well as continuing expenditures in research and development operations, reinforce its market position in the Neurorehabilitation market.

Key Developments:

  • In February 2023, Lupin Limited launched the first-of-its-kind computer and robotic-assisted Neurorehabilitation Center "Atharv Ability" in Mumbai. The center would provide rehabilitation programs for patients suffering from spinal cord & brain injury and other neurological conditions such as Parkinson's, multiple sclerosis, and cerebral palsy.

Segmentation

BY PRODUCT

  • Neuro-Robotic System
  • Wearable Devices
  • Brain Computer Interface
  • Non-Invasive Stimulators
  • Neuronal Prosthetics
  • Others

BY APPLICATION

  • Stroke
  • Traumatic Brain Injury (TBI)
  • Spinal Cord Injury (SCI)
  • Parkinson's Disease
  • Cerebral Palsy
  • Others

BY END-USER

  • Hospitals
  • Clinics
  • Rehabilitation Centers
  • Home Care Settings

BY Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Market Opportunities
  • 4.4. Porter's Five Force Analysis
    • 4.4.1. Bargaining Power of Suppliers
    • 4.4.2. Bargaining Power of Buyers
    • 4.4.3. Threat of New Entrants
    • 4.4.4. Threat of Substitutes
    • 4.4.5. Competitive Rivalry in the Industry
  • 4.5. Industry Value Chain Analysis

5. NEUROREHABILITATION MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Neuro-Robotic System
  • 5.3. Wearable Devices
  • 5.4. Brain-Computer Interface
  • 5.5. Non-Invasive Simulators
  • 5.6. Neuronal Prosthetics
  • 5.7. Others

6. NEUROREHABILITATION MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Stroke
  • 6.3. Traumatic Brain Injury (TBI)
  • 6.4. Spinal Cord Injury (SCI)
  • 6.5. Parkinson's Disease
  • 6.6. Cerebral Palsy
  • 6.7. Others

7. NEUROREHABILITATION MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Clinics
  • 7.4. Rehabilitation Centers
  • 7.5. Home Care Settings

8. NEUROREHABILITATION MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Taiwan
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

  • 10.1. Medtronic PLC
  • 10.2. Abbott Laboratories
  • 10.3. BIONIK
  • 10.4. Ekso Bionics Holdings Inc.
  • 10.5. DIH Medical Group
  • 10.6. ReWalk Robotics
  • 10.7. BioXtreme Ltd.
  • 10.8. Kinova
  • 10.9. Saebo Inc.